|
|
|
| home > white papers > Using Device Strategy to Drive R&D Productivity - Phillips-Medisize |
|
|
 WHITE PAPERS |
|
Phillips-Medisize
|
|
Using Device Strategy to Drive R&D Productivity
|
|
Biopharmaceutical companies face sustained pressure from all sides to develop better products at lower costs, delivering value to patients, payers and shareholders. Healthcare costs are rising globally at an unsustainable level, putting the entire healthcare delivery system under pricing pressure. Biopharmaceutical companies have become popular targets, evidenced by increasing scrutiny on prescription medicine prices, even though spending on medicine accounts for only about ~10% of overall spend.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Labguru integrates free video conferencing & documenting tool to support remote lab collaboration during COVID-19
2 April 2020, Cambridge MA – Electronic laboratory notebook (ELN)
pioneer, BioData, today announces its support for the global science
community with the introduction of a new video conferencing service in
its leading Labguru ELN platform, free of charge for all customers.
More info >> |
|
 |
White Papers |
 |
|
Quality Systems Guide
Research Quality Association
This guide concentrates on the core, underlying principles of quality that are pivotal – explicitly or implicitly – to all quality management standards that impact on research and development.
More info >> |
|
 |
Industry Events |
 |
Evolution Summit
20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL
The 22nd Evolution Summit is the premium forum bringing leading drug
development executives and solution providers together. As an
invitation-only event, taking place behind closed doors, the Summit
offers an intimate environment for a focused discussion of key new
drivers shaping drug development.
More info >> |
|
|
|
